✦ LIBER ✦

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study

✍ Scribed by Younossi, Zobair M.; Stepanova, Maria; Zeuzem, Stefan; Dusheiko, Geoffrey; Esteban, Rafael; Hezode, Christophe; Reesink, Hendrik W.; Weiland, Ola; Nader, Fatema; Hunt, Sharon L.

Book ID: 122179822
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 673 KB
Volume: 61
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2014.04.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P720 HEALTH-RELATED QUALITY OF LIFE (HRQ

✍ Younossi, Z.M.; Stepanova, M.; Zeuzem, S.; Reesink, H.W.; Weiland, O.; Nader, F. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 63 KB

P1114 PATIENT-REPORTED OUTCOMES (PROS) I

P1114 PATIENT-REPORTED OUTCOMES (PROS) IN CHRONIC HEPATITIS C PATIENTS WITH CIRRHOSIS TREATED WITH SOFOSBUVIR (SOF) CONTAINING REGIMENS

✍ Younossi, Z.M.; Stepanova, M.; Nader, F.; Nelson, D.; Lawitz, E.; Jacobson, I.M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Dyspnoea in patients with chronic hepati

Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

✍ Garib, Junia Rios; Garcia, Guilherme Freire; Teixeira, Rosângela; Lima e Silva, 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 151 KB

PIN92 Patient Reported Outcomes Among Ch

PIN92 Patient Reported Outcomes Among Chronic Hepatitis C Patients Re-Treated with Peginterferon Alfa-2A/Ribavirin After Non-response to Peginterferon Alfa-2B/Ribavirin in Spain

✍ A. Olveira; D. Rincon; M. Diago; J. Crespo; J.L. Calleja; J. Salmeron; R. Andrad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Patients' preferences and health utility

Patients' preferences and health utility assessment with SF-6D and EQ-5D in patients with chronic hepatitis C treated with sofosbuvir regimens

✍ Stepanova, M.; Nader, F.; Cure, S.; Bourhis, F.; Hunt, S.; Younossi, Z. M. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Simeprevir plus sofosbuvir, with or with

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

✍ Lawitz, Eric; Sulkowski, Mark S; Ghalib, Reem; Rodriguez-Torres, Maribel; Younos 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 555 KB